Safety Profile of Upadacitinib in Giant-Cell Arteritis

This chapter examines the safety aspects of upadacitinib for patients with giant-cell arteritis, focusing on potential cardiovascular risks. It addresses initial concerns and presents findings that show no increased risk of major cardiovascular events, while also noting concerns about zoster infections and creatine kinase levels.